Research

A new drug for Alzheimer's could reach the market in 2023

28/09/2022
The pharmaceutical companies Eisai and Biogen have just announced to the press the results of their monoclonal antibody Lecanemab, a drug targeted at the deposit of amyloid in the brain.

RCD Espanyol welcomes UAD users on World Alzheimer's Day

22/09/2022Day care and treatment
About thirty users of the Day Care Unit have visited the RCD Espanyol Sports City to commemorate World Alzheimer's Day together with several players and members of the club's staff.

The United States approves the use of Aducanumab: a treatment for Alzheimer's disease

11/06/2021Day care and treatment
Ace Alzheimer Center Barcelona participated in Biogen's clinical trial for the drug Aducanumab. During the clinical trial, we were the sixth center that was able to include the most people in the study worldwide and the first in Europe.

The Day Care Unit applies successful anti-COVID measures

02/02/2021Day care and treatment
Fundació ACE’s Day Care Unit, formed by the Day Centre, the Day Hospital and the Memory Workshops, ends the year 2020 without COVID-19 infections in their centres.

Face-to-face memory workshops are back

05/10/2020Day care and treatment
The users of the Daycare Unit have returned to Fundació ACE to continue their memory workshops in person

The Day Care Unit closes due to the outbreaks of COVID-19

30/07/2020Day care and treatment
From August 1st on, Fundació ACE's Day Center and Day Hospital will remain closed to protect the health of users and users against outbreaks of coronavirus (Covid-19).